Literature DB >> 19778295

Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

L C Ndhlovu1, J E Snyder-Cappione, K I Carvalho, F E Leal, C P Loo, F R Bruno, A R Jha, D Devita, A M Hasenkrug, H M R Barbosa, A C Segurado, D F Nixon, E L Murphy, E G Kallas.   

Abstract

Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. The majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.

Entities:  

Mesh:

Year:  2009        PMID: 19778295      PMCID: PMC2792825          DOI: 10.1111/j.1365-2249.2009.04019.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  NKT cells in HIV-1 infection.

Authors:  Demin Li; Xiao-Ning Xu
Journal:  Cell Res       Date:  2008-08       Impact factor: 25.617

2.  Autoimmunity due to molecular mimicry as a cause of neurological disease.

Authors:  Michael C Levin; Sang Min Lee; Franck Kalume; Yvette Morcos; F Curtis Dohan; Karen A Hasty; Joseph C Callaway; Joseph Zunt; Dominic Desiderio; John M Stuart
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

3.  In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells.

Authors:  J A Sakai; M Nagai; M B Brennan; C A Mora; S Jacobson
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

Review 4.  Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.

Authors:  Steven Jacobson
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Mycobacterial infection in natural killer T cell knockout mice.

Authors:  I Sugawara; H Yamada; S Mizuno; C Y Li; T Nakayama; M Taniguchi
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

7.  Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.

Authors:  Hiroto Kita; Olga V Naidenko; Mitchell Kronenberg; Aftab A Ansari; Paul Rogers; Xiao-Song He; Frits Koning; Toshifumi Mikayama; Judy Van De Water; Ross L Coppel; Marshall Kaplan; M Eric Gershwin
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.

Authors:  Michaela Lucas; Stephan Gadola; Ute Meier; Neil T Young; Gillian Harcourt; Anastasios Karadimitris; Nikki Coumi; Dave Brown; Geoff Dusheiko; Vincenzo Cerundolo; Paul Klenerman
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Distinct functional lineages of human V(alpha)24 natural killer T cells.

Authors:  Peter T Lee; Kamel Benlagha; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  10 in total

1.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.

Authors:  Marianne W Mureithi; Kristen Cohen; Ramona Moodley; Danielle Poole; Zenele Mncube; Anne Kasmar; D Branch Moody; Philip J R Goulder; Bruce D Walker; Marcus Altfeld; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-13       Impact factor: 2.205

3.  Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Mineki Saito
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-10

4.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

Review 5.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

Review 6.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

7.  MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

Authors:  Dominic Paquin-Proulx; Benjamin C Greenspun; Emanuela A S Costa; Aluisio C Segurado; Esper G Kallas; Douglas F Nixon; Fabio E Leal
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

8.  Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.

Authors:  Mineki Saito; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2012-02-06

Review 9.  Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito
Journal:  J Neurovirol       Date:  2013-08-14       Impact factor: 3.739

10.  The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Houshang Rafatpanah; Reza Farid Hosseini; Seyed Hassan Pourseyed
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.